FERRERO, Dario

FERRERO, Dario  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 144 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel human lymphokine that inhibits haematopoietic progenitor cell proliferation. 1984 TRUCCO M ;ROVERA G ;FERRERO D
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS 2014 Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. 2012 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs 2010 Crisà E; Venturino E; Passera R; Prina M; Schinco P; Borchiellini A; Giai V; Ciocca Vasino MA; Bazzan M; Vaccarino A; Boccadoro M; Ferrero D
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation. 1998 FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A
A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. 1986 SANTOLI D ;TWEARDY DJ ;FERRERO D ;KREIDER BL ;ROVERA G
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. 2001 M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C.
Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology. 1989 PILERI A ;FERRERO D ;MASSAIA M ;DIANZANI U ;BOCCADORO M
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. 2014 Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; Cambrin GR; Isidori A; Sica S; Abruzzese E; Speccha G; Rosti G; Alimena G.
Anemia in the Elderly: not Always what it Seems. 2016 Cerrano, Marco; Crisà, Elena; Giai, Valentina; Boccadoro, Mario; Ferrero, Dario
Angiocentric lymphoma: a case report. 1990 DARBESIO A ;FERRERO D
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders. 1986 Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E.
Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow. 1983 D. FERRERO; BROXMEYER HE; PAGLIARDI GL; VENUTA S; LANGE B; PESSANO S; ROVERA G
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement. 1987 Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F
Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an Italian compassionate program 2012 Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P.
The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis. 2012 Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti.
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia 2019 Dragani M.; Rege-Cambrin G.; Ferrero D.; Abruzzese E.; Pregno P.; Elena C.; Cedrone M.; Santoro M.; Andreani G.; Saglio G.; Fava C.
c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells. 1998 M. BRIZZI; A. ROSSO; P. DENTELLI; D. FERRERO; L. LANFRANCONE ; L. PEGORARO.
Can pegylated interferon improve the outcome of polycythemia vera patients? 2017 Crisà, E; Cerrano, M; Beggiato, E; Benevolo, G; Lanzarone, G; Manzini, Pm; Borchiellini, A; Riera, L; Boccadoro, M; Ferrero, D.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? 2021 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.